Repeatability of inflammatory analysis in induced sputum samples in COPD

M. Boorsma, R. Lutter, M. van de Pol, H. M. Jansen, R. E. Jonkers (Amsterdam, The Netherlands)

Source: Annual Congress 2004 - Noninvasive approaches to measure airway epithelial cell function
Session: Noninvasive approaches to measure airway epithelial cell function
Session type: Poster Discussion
Number: 2936
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Boorsma, R. Lutter, M. van de Pol, H. M. Jansen, R. E. Jonkers (Amsterdam, The Netherlands). Repeatability of inflammatory analysis in induced sputum samples in COPD. Eur Respir J 2004; 24: Suppl. 48, 2936

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of blood and sputum analysis in evaluation of eosinophilic COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Cytokine profile of blood and sputum in COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006

Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Cytokine profile of blood and sputum at infectional COPD exacerbation
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008

Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Applications of induced sputum sampling in asthma and COPD
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Characteristic of cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Inflammatory cell profiles in asthmatic infants assessed by induced sputum
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003